sugiol has been researched along with Prostatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Han, DC; Jeon, YJ; Jung, SN; Kang, JS; Kim, HN; Kwon, BM; Lee, YJ; Shin, DS; Yun, J | 1 |
| Adhikari, A; Al-Majid, AM; Ali, Z; Ayatollahi, SA; Choudhary, MI; Hussain, A; Sattar, SA | 1 |
2 other study(ies) available for sugiol and Prostatic Neoplasms
| Article | Year |
|---|---|
Sugiol inhibits STAT3 activity via regulation of transketolase and ROS-mediated ERK activation in DU145 prostate carcinoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Diterpenes; Enzyme Activation; Enzyme Inhibitors; Female; Genes, Reporter; Humans; Male; MAP Kinase Signaling System; Mice, Inbred BALB C; Mice, Nude; Neoplasm Proteins; Prostatic Neoplasms; Protein Tyrosine Phosphatases, Non-Receptor; Reactive Oxygen Species; STAT3 Transcription Factor; Transketolase; Tumor Burden; Xenograft Model Antitumor Assays | 2015 |
Diterpenoids including a novel dimeric conjugate from Salvia leriaefolia.
Topics: Antineoplastic Agents, Phytogenic; Diterpenes; HeLa Cells; Humans; Iran; Male; Molecular Structure; Phytotherapy; Plant Extracts; Plant Roots; Prostatic Neoplasms; Salvia | 2012 |